Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Gusberg

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
American Journal of Obstetrics and Gynecology|January 1, 1980
Leukocyte migration enhancement as an indicator of immunologic enhancement. III. Common denominators of pregnancy and malignancyN Gleicher, P Beers, C J Cohen, et al.
The Mount Sinai Journal of Medicine, New York|March 1, 1981
Effect of cis-diamminedichloroplatinum chemotherapy on the survival of patients with advanced ovarian cancerH W Bruckner, C J Cohen, G Deppe, et al.
Cancer Treatment Reports|April 1, 1978
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapyH W Bruckner, C J Cohen, R C Wallach, et al.
American Journal of Obstetrics and Gynecology|April 15, 1983
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)C J Cohen, J D Goldberg, J F Holland, et al.
Cancer|May 1, 1981
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinH W Bruckner, C J Cohen, J D Goldberg, et al.
American Journal of Obstetrics and Gynecology|March 15, 1983
Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerH W Bruckner, C J Cohen, J D Goldberg, et al.
Cancer|May 15, 1990
Breakout IV. Health professional concerns in the practice settingS B Gusberg, J Lowman, I D Fleming, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
American Journal of Obstetrics and Gynecology|January 1, 1980
Leukocyte migration enhancement as an indicator of immunologic enhancement. III. Common denominators of pregnancy and malignancyN Gleicher, P Beers, C J Cohen, et al.
The Mount Sinai Journal of Medicine, New York|March 1, 1981
Effect of cis-diamminedichloroplatinum chemotherapy on the survival of patients with advanced ovarian cancerH W Bruckner, C J Cohen, G Deppe, et al.
Cancer Treatment Reports|April 1, 1978
Treatment of advanced ovarian cancer with cis=dichlorodiammineplatinum(II): poor-risk patients with intensive prior therapyH W Bruckner, C J Cohen, R C Wallach, et al.
American Journal of Obstetrics and Gynecology|April 15, 1983
Improved therapy with cisplatin regimens for patients with ovarian carcinoma (FIGO Stages III and IV) as measured by surgical end-staging (second-look operation)C J Cohen, J D Goldberg, J F Holland, et al.
Cancer|May 1, 1981
Improved chemotherapy for ovarian cancer with cis-diamminedichloroplatinum and adriamycinH W Bruckner, C J Cohen, J D Goldberg, et al.
American Journal of Obstetrics and Gynecology|March 15, 1983
Cisplatin regimens and improved prognosis of patients with poorly differentiated ovarian cancerH W Bruckner, C J Cohen, J D Goldberg, et al.
Cancer|May 15, 1990
Breakout IV. Health professional concerns in the practice settingS B Gusberg, J Lowman, I D Fleming, et al.
Pageof 8